| 928 |
214: Bile accumulation, Pathological condition |
87: Release, Cytokine |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3510 |
214: Bile accumulation, Pathological condition |
1115: Increase, ROS |
Apr 3, 2025 |
Apr 3, 2025 |
1 AOP
|
| 877 |
857: Binding as antagonist, Antagonist binding to PPARalpha ligand binding domain |
858: Decreased, PPARalpha transactivation of gene expression |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 666 |
667: Binding at picrotoxin site, iGABAR chloride channel |
64: Reduction, Ionotropic GABA receptor chloride channel conductance |
Nov 29, 2016 |
Apr 29, 2019 |
1 AOP
|
| 3183 |
2218: Binding of (ant)agonist to liver X receptor |
2221: LXR activity, altered |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 3187 |
2218: Binding of (ant)agonist to liver X receptor |
2115: Cholesterol metabolism |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 3184 |
2219: Binding of (ant)agonist to PPAR alpha |
2216: Binding of antagonist to thyroid hormone receptor |
Apr 12, 2024 |
Apr 12, 2024 |
None
|
| 3185 |
2219: Binding of (ant)agonist to PPAR alpha |
2222: PPAR alpha activity, altered |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 3188 |
2219: Binding of (ant)agonist to PPAR alpha |
2115: Cholesterol metabolism |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 3195 |
2219: Binding of (ant)agonist to PPAR alpha |
2223: Reduced number of oligodendrocytes |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 2319 |
1851: Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R) |
1115: Increase, ROS |
Apr 10, 2021 |
Apr 10, 2021 |
2 AOPs
|
| 919 |
875: Binding of agonist, Ionotropic glutamate receptors |
388: Overactivation, NMDARs |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 3506 |
875: Binding of agonist, Ionotropic glutamate receptors |
2078: Loss of drebrin |
Mar 9, 2025 |
Mar 9, 2025 |
1 AOP
|
| 360 |
387: Binding of agonist, NMDARs |
388: Overactivation, NMDARs |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 3182 |
2217: Binding of antagonist to glucocorticoid hormone receptor |
2220: GR antagonism |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 3181 |
2216: Binding of antagonist to thyroid hormone receptor |
1656: TR Antagnoism |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 228 |
201: Binding of antagonist, NMDA receptors |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 229 |
201: Binding of antagonist, NMDA receptors |
195: Inhibition, NMDARs |
Nov 29, 2016 |
Jun 13, 2018 |
2 AOPs
|
| 1023 |
998: Binding of antagonist, PPAR alpha |
1000: stabilization, PPAR alpha co-repressor |
Nov 29, 2016 |
Jun 11, 2018 |
1 AOP
|
| 1944 |
1653: Binding of inhibitor, mitochondrial complex III |
1542: Inhibition, Mitochondrial complex III |
Jun 7, 2019 |
Jun 7, 2019 |
1 AOP
|
| 1945 |
1654: Binding of inhibitor, mitochondrial complex IV |
1543: Mitochondrial Complex IV inhibition |
Jun 7, 2019 |
Jun 7, 2019 |
1 AOP
|
| 1946 |
1655: Binding of inhibitor, mitochondrial complex V |
1544: Mitochondrial Complex V inhibition |
Jun 7, 2019 |
Jun 7, 2019 |
1 AOP
|
| 933 |
888: Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I) |
887: Inhibition, NADH-ubiquinone oxidoreductase (complex I) |
Nov 29, 2016 |
Aug 25, 2017 |
3 AOPs
|
| 1833 |
1580: Binding of MSAs to microtubules |
1581: Disturbance in microtubule dynamic instability |
Jan 29, 2019 |
Jan 29, 2019 |
1 AOP
|
| 3556 |
2307: Binding to the QB site D1 protein |
1862: Decrease, Photosystem II efficiency |
Aug 5, 2025 |
Feb 23, 2026 |
1 AOP
|